Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Naphthylpiperazine antipsychotics synthesized at Faes

Dec. 1, 1998

Guilford presents two new series of NAALADase inhibitors

Nov. 30, 1998

Unimed receives U.S. patent protection for dronabinol in treatment of dementia

Nov. 30, 1998

SSRI promising in the treatment of children and adolescents with OCD

Nov. 30, 1998

International study focuses on riluzole as a new approach to treating PD

Nov. 30, 1998

Nortran announces positive phase II trial results with RSD-921

Nov. 30, 1998

Human neural stem cells as source of transplantable cells for CNS disorders

Nov. 26, 1998

Grape polyphenols now shown to have neuroprotective properties

Nov. 26, 1998

Pharmacological profile of PNU-99194A, a D3-preferring dopamine antagonist, reviewed

Nov. 26, 1998

U.S. patent issues for conantokin-G and derivatives

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...